3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and ergoline

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with ergoline in 2 studies

Compound Research Comparison

Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)	Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)	Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)	Studies (ergoline)	Trials (ergoline)	Recent Studies (post-2010) (ergoline)
330	40	33	4,324	381	441

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brücke, T; Chiueh, CC; Cohen, RM; Kung, HF; McLellan, CA; Singhaniyom, W; Tsai, YF	1
Drukarch, B; Goosen, C; Sahadat, MC; Stoof, JC; van Royen, EA; Verhoeff, NP; Vermeulen, RJ; Wolters, EC	1

Other Studies

2 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and ergoline

Article	Year
Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist. Brain research, 1988, Jun-21, Volume: 453, Issue:1-2 Topics: Animals; Autoradiography; Benzamides; Binding, Competitive; Caudate Nucleus; Dopamine; Ergolines; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Olfactory Bulb; Pyrrolidines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Septal Nuclei	1988
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys. Synapse (New York, N.Y.), 1994, Volume: 17, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholine; Animals; Behavior, Animal; Benzamides; Binding, Competitive; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; Functional Laterality; Macaca mulatta; Male; Neostriatum; Pyrrolidines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Rotation; Stereotyped Behavior; Tomography, Emission-Computed, Single-Photon	1994

Article

Year

Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.

Brain research, 1988, Jun-21, Volume: 453, Issue:1-2

Topics: Animals; Autoradiography; Benzamides; Binding, Competitive; Caudate Nucleus; Dopamine; Ergolines; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Olfactory Bulb; Pyrrolidines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Septal Nuclei

1988

No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.

Synapse (New York, N.Y.), 1994, Volume: 17, Issue:2

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholine; Animals; Behavior, Animal; Benzamides; Binding, Competitive; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; Functional Laterality; Macaca mulatta; Male; Neostriatum; Pyrrolidines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Rotation; Stereotyped Behavior; Tomography, Emission-Computed, Single-Photon

1994